Public Comment - 60d FRN

Document Metadata:CDC-2017-0011-0002

Document Details
Docket ID:

CDC-2017-0011

Docket Title:

A Novel Framework for Structuring Industry-Tuned
Public-Private Partnerships and Economic Incentives for U.S.
Health Emergency Preparedness and Response 0920-17NW

Document File:
Docket Phase:

Notice

Phase Sequence:

1

Original Document ID:

CDC-2017-0011-DRAFT-0002

Current Document ID:

CDC-2017-0011-0002

Title:

: Kermit Kubitz Comment from (name)

Number of Attachments:

0

Document Type:

PUBLIC SUBMISSIONS

Document Subtype:
Comment on Document ID:

CDC-2017-0011-0001

Comment on Document Title: A Novel Framework for Structuring Industry-Tuned
Public-Private Partnerships and Economic Incentives for U.S.
Health Emergency Preparedness and Response 0920-17NW 2017-08540
Status:

Posted

Received Date:

06/26/2017

Date Posted:

06/28/2017

Posting Restriction:

No restrictions

Submission Type:

Web

Number of Submissions:

1

Document Optional Details
Status Set Date:

06/28/2017

Current Assignee:

NA

Status Set By:

Burroughs-Stokes, Kennya LaTrice (CDC)

Comment Start Date:

04/27/2017

Comment Due Date:

06/26/2017

Tracking Number:

1k1-8x6r-v9o7

Page Count:

1

Total Page Count
Including Attachments:

1

Submitter Info
Comment:

The notion of public private partnerships may be useful, but
the CDC interviews should ensure that not just industry
leaders but small innovative companies are included. Dealing
with "Big Pharma" alone may not lead to the best results as
small companies like Biocryst or Radius or other BSAV
developers may have good ideas.

First Name:

Kermit

Last Name:

Kubitz

ZIP/Postal Code:

94127

Email Address:

[email protected]

Organization Name:
Cover Page:

Document Optional Details
Submitter Info
Comment:

The notion of public private partnerships may be useful, but
the CDC interviews should ensure that not just industry
leaders but small innovative companies are included. Dealing
with "Big Pharma" alone may not lead to the best results as
small companies like Biocryst or Radius or other BSAV
developers may have good ideas.

First Name:

Kermit

Last Name:

Kubitz

ZIP/Postal Code:

94127

Email Address:

[email protected]

Organization Name:
Cover Page:

Document Optional Details
Submitter Info
Comment:

The notion of public private partnerships may be useful, but
the CDC interviews should ensure that not just industry
leaders but small innovative companies are included. Dealing
with "Big Pharma" alone may not lead to the best results as
small companies like Biocryst or Radius or other BSAV
developers may have good ideas.

First Name:

Kermit

Last Name:

Kubitz

ZIP/Postal Code:

94127

Email Address:

[email protected]

Organization Name:
Cover Page: